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Objective: Better prediction of tissue prognosis in acute stroke might improve 
treatment decisions. We hypothesized that there are metabolic ischemic 
disturbances measurable non-invasively by proton MR spectroscopy (1HMRS) that 
occur earlier than any structural changes visible on diffusion tensor imaging (DTI), 
which may therefore serve for territorial identification of “tissue at risk”. Methods: We 
performed multi-voxel 1HMRS plus DTI within a maximum of 26 hours, and DTI at 
three-seven days, after ischemic stroke. We compared choline, lactate, NAA, 
creatine concentrations in normal-appearing voxels that became infarcted("infarct 
expansion”), with normal-appearing voxels around the infarct that remained 
“healthy”(“non-expansion”) on follow-up DTI. Each “infarct expansion” voxel was 
additionally classified as either “complete infarct expansion”(infarcted tissue on 
follow-up DTI covered ≥50% of the voxel) or “partial infarct expansion”(<50% of 
voxel). Results: In 31 patients (NIHSS:0–28) there were 108 infarct "non-expansion” 
voxels and 113 infarct "expansion” voxels (of which 80 were “complete expansion” 
and 33 “partial expansion” voxels). Brain choline concentration increased for each 
change in expansion category from "non-expansion", via "partial expansion" to 
"complete expansion" (2423, 3843, 4158i.u.; p<0.05). Changes in lactate, NAA and 
creatine concentrations in expansion category were insignificant although for lactate 
there was a tendency to such association. Conclusions: Choline concentration 
measurable with 1HMRS was elevated in peri-ischemic normal-appearing brain that 
became infarcted by three-seven days. The degree of elevation was associated with 
the amount of infarct expansion. 1HMRS might identify DTI-normal appearing tissue 
at risk of conversion to infarction in early stroke. 
 




In clinical stroke practice, management decisions, including use of thrombolytic 
treatment, are based on physical examination, neuroimaging to exclude hemorrhage, 
and time from stroke onset to treatment, assuming that there is “tissue at risk” of 
infarction that could be salvaged. However, for some patients, very early time 
windows are already too late, whilst others may have salvageable tissue for many 
hours after stroke, making the time window alone too non-specific1,2.  
Currently there is no reliable, sensitive and specific method for early non-invasive 
determination of tissue at risk: the mismatch between Diffusion- and Perfusion-
Weighted Imaging is still being evaluated1-4, and there are no CSF or blood markers 
that diagnose stroke or predict prognosis reliably5,6. 
We hypothesized that in acute ischemic stroke, metabolic disturbances could be 
measurable in ischemic tissue much earlier than any structural changes. If true, 
changes in brain metabolite concentrations in normal appearing tissue on diffusion 
imaging outside the lesion soon after ischemic stroke measured with Magnetic 
Resonance Spectroscopy (MRS)7,8 might predict the likelihood and direction of 
further infarct expansion and hence prognosis. To test this hypothesis, we compared 
concentrations of selected brain metabolites measured with MRS in the normal-
appearing tissue around the acute infarct as seen on Diffusion Tensor Imaging (DTI) 
early after stroke that converted to infarction by three to seven days, with that which 
remained normal on DTI. The selection of metabolites for this study was based on 
the assumptions that they should represent important elements in pathophysiological 
pathways following acute stroke and that their concentrations are readily observable 
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We prospectively recruited patients with acute ischemic stroke and without 
contraindications to Magnetic Resonance Imaging (MRI) admitted to our hospital 
acute stroke service. Each patient was carefully examined by a stroke physician who 
measured stroke severity using National Institutes of Health Stroke Scale (NIHSS) 
and determined stroke sub-type by the Oxfordshire Community Stroke Project 
(OCSP) classification9. Patients underwent MRI as soon as possible after stroke but 
within a maximum of 24 hours from onset. Follow-up MRI was performed at three to 
seven days after stroke. Onset was defined as the time when signs were first noticed 
by a patient, or symptoms first observed, or, if a patient awoke already having stroke 
symptoms, the time last known to be well.  
 
Standard Protocol Approvals, Registrations, and Patient Consents 
The study was approved by the Lothian Research Ethics Committee on human 
experimentation and written informed consent was obtained from the patients or 
assent from their relatives. 
 
Diffusion and Spectroscopy Techniques 
All MR data were obtained on a GE Signa HDX 1.5T (General Electric, Milwaukee, 
WI, USA) scanner with self-shielding gradients (33 mT/m maximum) and a ‘birdcage’ 
quadrature head coil. In each patient we performed axial T2-weighted fast spin-echo 
and FLuid Attenuated Inversion Recovery (FLAIR) imaging, axial DWI and/or DTI 
with field-of-view (FOV) 240x240 mm, 15 axial slices of thickness 5 mm, slice gap 1 
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sensitizing gradients with scalar b-values of 1000 s/mm2 applied in six non-collinear 
directions, and Multi-voxel Point Resolved Spectroscopy (PRESS)-localized proton 
MRS (1HMRS, FOV 320x320 mm, slice thickness 10 mm, acquisition matrix 24x24, 
echo time 145 ms and repetition time 1000 ms). DTI and 1HMRS with FLAIR and T2* 
imaging were performed on admission, and DTI, FLAIR, and T2* at three-seven days 
after stroke. The 1HMRS voxel grid was carefully centered on the slice showing the 
maximum ischemic lesion extent on DTI (Figures 1 and 2) and placed within brain to 
avoid contamination of the spectra by lipid signal from bone marrow or subcutaneous 
tissue, but to include as much as possible of the brain as possible. We used the 
scanner’s standard three-pulse CHEmical Shift Selective (CHESS) water 
suppression and shimming, optimized on the slice of interest. Additional saturation 
bands were placed around the PRESS box to minimize lipid contamination. Each 
1HMRS data set took approximately nine minutes to acquire, and the data were 
effectively ‘averaged’ over this period. Bulk patient motion and eddy current-induced 
artifacts were removed from the DTI data using a three dimensional (3D) 
computational image alignment program to register the component echo-planar 
imaging volumes to the T2-weighted volumes acquired with the DTI protocol. Maps of 
the average DTI signal were obtained from the six DTI images acquired for each 
slice. 
Spectroscopic images were interpolated to a 32x32 matrix yielding 1000 mm3 voxels 
and all processing was carried out on a voxel-by-voxel basis after setting the residual 
water signal in each voxel to a standard chemical shift of 4.70 ppm. All spectroscopic 
data were modelled in the time domain by five Gaussian components (corresponding 
to choline, creatine, N-acetyl aspartate (NAA) and the lactate doublet) using the 
Advanced Method for Accurate Robust and Efficient Spectral Fitting (AMARES) 
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algorithm within the Magnetic Resonance User Interface (MRUI) package 
(http://www.mrui.uab.es/mrui). The data were transformed to spectra for display and 
visual quality control purposes. 
 
Metabolite Concentrations 
Choline, creatine, NAA and lactate were identified by their characteristic 
appearances at echo time 145 ms (Figure 1). Metabolite quantification took into 
account coil loading (using the scanner’s radiofrequency transmitter gain) and 
receiver gain thus enabling inter-subject (and obviously intra-subject) comparison of 
individual metabolite concentrations. Careful patient set-up ensured between subject 
set-up reproducibility and good coil uniformity: we previously found that coil 
uniformity is very good across an axial slice near the centre of the coil (data not 
published). Our metabolite concentration unit was  an ‘institutional unit’ (i.u.).  
 
Tissue Classification and Estimation of Tissues Metabolites’ Concentrations  
1HMRS and DTI data were co-registered using an affine transformation. The multi-
voxel MRS grid was superimposed onto the admission DTI using software designed 
in-house. The grid voxels on admission DTI were classified as falling on or outside 
the acute DTI hyperintense ischemic lesion blind to all other information; then the 
voxel grid was compared with the DTI lesion appearance at three-seven days to 
identify voxels superimposed on tissue located outside the lesion that were normal 
on admission and remained normal on follow-up, or voxels superimposed on tissue 
located outside the lesion that were normal on admission but became hyperintense 
on DTI at three-seven days, also blind to all other data. We used the diffusion image 
at three-seven days as an indication of infarct growth because at three-seven days 
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diffusion imaging usually mirrors the three-seven day T2 or FLAIR appearance10, and 
is easier to assess visually than the B0-T2 image. Although the three-seven day 
infarct extent is not the final infarct (because infarct evolution is generally considered 
to be complete by three months), it is a useful indicator of early lesion growth due to 
recruitment of early penumbral tissue into the infarct before other secondary events 
can influence infarct extent (e.g. recurrent stroke, hypotension). 
The concentrations of choline, creatine, NAA and lactate from each voxel in the 
spectroscopy grid were extracted and compared between: 1) voxels on the 
admission DTI that appeared normal around the ischemic lesion, but that converted 
to infarction on the follow-up DTI ("infarct expansion” voxels) and 2) voxels on the 
admission DTI that appeared normal around the ischemic lesion, which remained 
“healthy” on the follow-up DTI ("non-expansion” voxels). 
Additionally, each “infarct expansion” voxel was classified as either “complete infarct 
expansion” voxel (infarcted tissue on the follow-up DTI covered over 50% of each 
individual voxel) or “partial infarct expansion” voxel (infarcted tissue on the follow-up 
DTI covered less than 50% of each individual voxel); Figure 2. The subdivision was 
introduced to investigate whether the metabolite concentration measured early after 
stroke in peri-infarcted tissue can be used for estimating the magnitude of potential 
infarct expansion (quantitative analysis) in addition to making prognosis on infarct 
expansion on a “yes” or “no” basis. 
 
Statistical Analysis 
We compared choline, creatine, NAA and lactate concentrations in “non-expansion” 
and “expansion” voxels using a linear mixed model. We tested the change in 
metabolite concentrations per change in expansion category: from “non-expansion”, 
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via "partial expansion” (below 50% of each voxel), to “complete expansion” (over 
50% of each voxel). We used the logarithmic transformations (log) of the metabolite 
concentrations rather than their raw values because the model fitted better when 
metabolite concentrations were linear. 
 
Results 
We recruited 31 patients (mean age: 74 years; range: 45-88) with acute ischemic 
stroke between December 2007 and March 2009 with admission and follow-up 
imaging. According to OCSP classification9 there were 11 TACS, 12 PACS, 5 LACS, 
2 POCS, and 1 of undetermined subtype. The mean NIHSS was 10, median 7, 
range: 0-28. The mean time from stroke onset to admission MRI was 16.3 hours, 
median 17 hours, range four to 26 hours. Four patients underwent initial MRI by two 
hours beyond the designed 24 hours but were included in the analysis (decision 
taken blind to any information on the results) as the benefits (more reliable statistics 
in a larger cohort) outweighed the drawbacks. We identified 108 "non-expansion” 
voxels and 113 "expansion” voxels amongst which there were 80 “complete 
expansion” voxels and 33 “partial expansion” voxels. Amid 31 patients there were 27 
with at least one “non-expansion” voxel and 20 with one or more “expansion” voxels. 
Among five patients classified as LACS on admission, definite lesion growth was 
observed in three using our voxel classification. 
 
Choline 
Mean brain choline concentration in "healthy-looking" voxels on initial DTI that 
converted to infarction on the follow-up DTI (“expansion” voxels) was higher than in 
DTI tissues immediately outside the lesion which remained “healthy-looking” on the 
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follow-up DTI (“non-expansion” voxels; Figure 3); the log of the choline concentration 
increased by 0.48 units (95% CI 0.0069, 0.95) for each change in expansion 
category from the baseline of "non-expansion", through ”partial” to “complete” 
expansion, (p=0.047; Figure 3). 
 
Lactate 
Although lactate concentration was highest in “complete expansion” voxels and 
lowest in “non-expansion” voxels (“complete expansion”: 1078; ”partial expansion”: 
962; “non-expansion”: 654 i.u.), the change in tissue lactate concentration with 
“expansion” category was not significant (Figure 4). 
 
N-acetyl Aspartate 
There was no difference in NAA concentration in “expansion” versus “non-expansion” 
voxels (p=0.60; Figure 4). 
 
Creatine 
There was no difference in creatine concentration in “expansion” versus “non-
expansion” voxels (p=0.13; Figure 4). 
 
Discussion 
We found that choline concentration measured by 1HMRS in DTI-normal appearing 
tissue located around the ischemic lesion within the first 26 hours from stroke onset 
was elevated in those voxels that became infarcted on DTI within the next few days. 
Moreover, the degree of ischemic expansion was associated with the degree of 
elevation of choline concentration. Further studies are required to determine whether 
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choline concentration is a reliable, sensitive or specific measure for predicting infarct 
growth, including identification of the potential threshold values, and therefore could 
be used to support treatment decisions in routine practice. 
We speculated that metabolite concentrations might have prognostic value because 
some metabolic products are pathophysiologically likely to mirror cellular 
sufficiency/insufficiency at the time of imaging. This is in contrast to other approaches 
to detect “tissue at risk”, for example perfusion imaging (including DWI/PWI 
mismatch), which gives an indirect estimate of tissue state by extrapolating from 
blood flow levels11,12. 
Hypothetically, in ischemic stroke patients, thrombolytic treatment might be 
considered over six hours from onset if there was still a high probability of further 
lesion expansion and if this could be assessed reliably and non-invasively on 
admission. However, as this is only speculative at this stage, further studies are 
required involving prospective 1HMRS metabolite measurement in acute ischemic 
stroke with clinical characteristics, ideally in patients treated with tissue plasminogen 
activator (tPA). Importantly, the time needed to obtain 1HMRS data seems 
acceptable in clinical setting as it takes not longer than ten minutes (much less in 
some circumstances). Although currently our approach demands specialist off line 
image processing, all MR manufacturers now provide MRS processing software on 
console, which could be used in routine practice enabling results to be obtained 
within reasonable time after MRI. 
Several previous studies assessed metabolite concentrations measured by MRS to 
predict final infarct size, clinical deficit or functional outcome11-16. However, with few 
exceptions11,12,16, they mainly focused on metabolites measured within the lesion 
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disturbances in anatomically normal peri-infarct tissue (on DTI) and future qualitative 
and quantitative ischemic changes on DTI in the same tissue. This approach might 
allow determination of the anatomical direction of lesion expansion, estimate 
prognosis for a particular brain region, or possibly predict the magnitude of future 
ischemic changes (“partial” or “complete” expansion). 
We selected lactate, NAA, choline and creatine because their concentrations are 
readily observable in a relatively short scanning time using a widely available MRS 
technique. The short scanning time is important in managing severely ill stroke 
patients as it does not significantly delay interventions in clinical practice7,8. 
Concentrations of other metabolites measurable with longer scanning sessions (such 
as glutamate) might be of support in estimating “penumbra” but are currently much 
more difficult to measure reliably in clinical practice, although their utility for this 
approach should be also investigated in the future. 
Previous studies on choline pathophysiology in the brain showed that mild hypoxia 
significantly increased cerebral choline levels17 and its concentration decreased 
within days of ischemia-induced membrane rupture18. The effect of mild hypoxia 
would be consistent with choline concentration being highest in the tissue which 
became infarcted, as in our results, although it is unlikely that membrane rupture 
would fit with our results as this is usually a late occurrence in established infarction 
when the lesion would be clearly visible on DTI, not in normal-appearing tissue. The 
hypotheses that might explain our finding of elevated choline and progression of 
penumbral tissue to infarction include upregulation of genes for enzymes responsible 
for metabolism of free choline, phosphatidylcholine (PC; a compound containing 95% 
of the total pool of body choline), phosphocholine or CDP-choline (intermediates 
towards PC synthesis), such as CTP:phosphocholine cytidylyltransferase, or body 
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choline redistribution for the benefit of the ischemic brain19. These mechanisms might 
stimulate and enable neurite branching or stabilization of neurolemma, and thus 
promote tissue salvage19. Alternatively, patients whose ischemic lesion grew might 
have had lower brain choline concentrations before stroke, and therefore their brains' 
cells were prone to quicker membrane destabilization and thus to infarction. 
We recently showed that choline is not a “stable” metabolite in acute stroke lesions, 
but changes with time after stroke20. This questioned the commonly regarded 
potential of choline to serve as a denominator for other metabolite concentration 
measurements, which may perhaps be the main reason for missing it as a marker of 
tissue at risk of infarction in its own right. Future studies are needed to explain the 
pathophysiological background of elevated choline concentration early after acute 
ischemia prior to any structural changes in the brain on DTI. 
The increase in lactate concentration is the net effect of its overproduction, impaired 
utilization and decreased washout in ischemic brain and might correlate with oxygen 
deprivation8,12,21-24. In stroke patients, lactate concentration is the highest in the 
lesion core, and then in the penumbral tissue as defined by DWI/PWI mismatch11,12 
or in a rim of normal tissue on DTI immediately outside the lesion8. In previous 
studies11,12 lactate correlated with the apparent diffusion co-efficient (ADC) and 
perfusion values but not NAA, thus confirming that all of these measures are markers 
of the presence of ischemia though not necessarily of tissue fate. In our cohort, brain 
lactate concentration increased from "non-expansion" through “partial expansion", to 
"complete expansion" tissue but the differences were not significant. Therefore a 
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NAA, a compound nearly exclusively localised in adult neurons decreases in 
ischemic stroke, the level of reduction being related to the severity of ischemia12,14,25-
30. It is considered as a marker of neuronal death but also of tissue dysfunction26,27. 
However, in agreement with previous studies12, we found that NAA concentration did 
not identify “active penumbra” in acute stroke. This is explainable physiologically 
because our metabolite measurements were performed when all analysed tissues 
were radiologically normal on DTI, prior to neuronal death. These results are also 
consistent with previous findings showing that although NAA was decreased in the 
lesion core, its concentration remained normal outside the visible infarct in penumbral 
tissue11,12,16,25,28-30. 
We had hypothesized that decreased brain concentrations of creatine might be 
associated with conversion to infarction because creatine inhibits caspase-mediated 
neuronal death31,32. However, we did not find that 1HMRS-measured creatine 
concentrations identified “tissue at risk”, which might also question its putative 
neuroprotective role31,32. 
This study has several limitations. We were only able to recruit and repeat imaging 
on 31 subjects, a relatively small patient cohort. We have not compared metabolite 
concentrations with cerebral perfusion data which might be helpful to explain the 
pathophysiology background for some of our results. For example, elevated lactate in 
normal appearing voxels immediately outside the infarct would be consistent with a 
perfusion deficit (i.e. DWI/PWI mismatch) as in previous studies12,14.  
We compared the images from different time points voxel-by-voxel manually, a time-
consuming and demanding procedure, and in some patients we did not manage to 
obtain identical admission and follow-up brain sections. Future developments might 
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image location between visits. We did not divide patients according to the time from 
stroke onset to imaging, and this may have influenced the results as tissue 
biochemical processes are much more dynamic than changes in structure. However, 
any subdivision of a 31-subject cohort would not produce reliable statistics. 
Additionally, the method for determining “tissue at risk” should be usable at any time 
from stroke onset. On the other hand, there might be different ranges of brain 
metabolite concentrations indicating the likelihood of conversion to infarction at 
different time points from stroke. Finally, the in vivo 1HMRS has several physical 
limitations, as listed and discussed in detail previously8. 
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Figure 1. Examples of 1HMRS spectra from different brain regions defined on DTI of 
an acute ischemic stroke patient: lesion core (0400), infarct expansion area (0398), 
contralateral normal tissue (0561 and 0622). 
Figure 2. Example of spectroscopy voxel categories according to the appearance of 
the brain on DTI and the changes of its appearance on the follow-up DTI. The voxel 
grid numbering on the follow-up is not consistent with the one on the admission 
image. 
Figure 3. Gradual increase in brain choline concentration (mean of patients’ means 
shown) with DTI infarct “expansion” characteristics (p<0.05). 
Figure 4. Brain concentration of metabolites (mean of patients’ means shown) in 
infarct “non-expansion” versus infarct “expansion” voxels (differences were not 
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Figure 3. Gradual increase in brain choline concentration (mean of patients’ means 















































Figure 4. Brain concentration of metabolites (mean of patients’ means shown) in 
infarct “non-expansion” (light columns) versus infarct “expansion” (dark columns) 
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Figure 1. Examples of 1HMRS spectra from different brain regions defined on DTI of 
an acute ischemic stroke patient: lesion core (0400), infarct expansion area (0398), 
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Figure 3. Gradual increase in brain choline concentration (mean of patients’ means 
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Figure 4. Brain concentration of metabolites (mean of patients’ means shown) in 
infarct “non-expansion” (light columns) versus infarct “expansion” (dark columns) 
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